top
Search terms
Results 1 - 9 of 9 - ordered by :
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Editorial, Nicolas Danchin, Etienne Puymirat, François Schiele

Date : 21/01/2016 Item size : 184766 bytes
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Heart

David M Shavelle Correspondence to David M Shavelle, Division of Cardiovascular Medicine, University of Southern California, 1510 San Pablo Street, Suite 322, Los Angeles, CA 90033, USA; ...

Heart, Review, David M Shavelle

Date : 01/04/2016
Heart

Stent thromboses are rare but potentially fatal complications after coronary stent implantation.2 Different factors have been identified that independently correlate with the risk for stent ...

Heart, Education in Heart, Helge Möllmann, Holger M Nef, Christian W Hamm

Date : 01/06/2010
Heart

Together, these are among the factors that predispose to stent thrombosis (ST). [...]dual antiplatelet therapy (DAT), which consists of aspirin and a thienopyridine, forms the cornerstone of ...

Heart, Featured editorial, Abhiram Prasad, David R Holmes

Date : 01/06/2009
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Danchin, Nicolas, Puymirat, Etienne, Schiele, François

Date : 21/01/2016
Ehjournal

Current management of ACS consists of acute administration of antiplatelet and anticoagulant agents, revascularization procedures [plus reperfusion therapy with lytic agents or percutaneous coronary ...

European Heart Journal, Van de Werf, Frans

Date : 01/11/2010
Escardio

Efficacy and safety of dual antiplatelet therapy and risk stratification tools 3.1 DAPT for the prevention of stent thrombosis 3.2 DAPT for the prevention of spontaneous myocardial infarction 3.3 ...

Date : 26/08/2017
Escardio

Hypersensitivity to aspirin in patients with coronary artery disease : rapid desensitisation is feasible Published data are limited, yet there are a series of patients (including patients with ...

Date : 31/05/2005